Skip to main content
SpringerLink
Log in

Allogeneic bone marrow transplantation for high risk non-hodgkin's lymphoma during first complete remission

  • Original Articles
  • Published:
Blut Aims and scope Submit manuscript

Summary

Allogeneic bone marrow transplantation from histocompatible sibling donors was performed in six patients with extranodal involvement of high grade lymphoma during first complete remission. Five patients had lymphoblastic lymphoma and one had diffuse undifferentiated lymphoma. The cytoreductive/immunosuppressive regimen consisted of total body irradiation and high dose cyclophosphamide. Four patients are alive in complete remission at 8 months, 14 months, 21 months and 47 months post transplantation. One patient who relapsed 7 months after his initial transplantation underwent a second transplantation but another relapse 17 months later led to his death. One patient died of chronic graft-versus-host disease and at autopsy there was no evidence of lymphoma. These data demonstrate that allogeneic bone marrow transplantation can produce durable remissions in patients with high grade lymphoma who present with bone marrow, central nervous system and/or skin involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Appelbaum FR, Sullivan K, Thomas ED, Buckner CD, Clift R, Deeg HJ, Fefer A, Hill R, Sanders J, Stewart P, Storb R (1985) Treatment of malignant lymphoma in 100 patients with chemoradiotherapy and marrow transplantation. Exp Hematol 13: Suppl. 18: 321 (abstract)

    Google Scholar 

  2. Appelbaum FR, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Neiman PE, Sanders J, Stewart P, Storb R, Sullivan K (1983) Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogeneic marrow transplantation. Hematol Oncol 1: 149–157

    Google Scholar 

  3. Armitage JO, Dick FR, Corder MP, Garneau SC, Platz CE, Slymen DJ (1982) Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP). Cancer 50: 1695–1702

    Google Scholar 

  4. Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL (1980) Bone marrow ablation and allogeneic marrow transplantation in acute leukemia. N Engl J Med 302: 1041–1046

    Google Scholar 

  5. Blume KG, Forman SJ, O'Donnell MR, Doroshow JH, Krance RA, Nademanee AP, Snyder DS, Fahey JL, Findley DO, Schmidt GM, Metter GE (1987) Total body irradiation and high dose VP 16: An effective preparatory regimen for bone marrow transplantation of patients with advanced hematologic malignancies. Blood 69: 1015–1020

    Google Scholar 

  6. Coleman CN, Cohen JR, Burke JS, Rosenberg SA (1981) Lymphoblastic lymphoma in adults: Results of a pilot protocol. Blood 57: 679–684

    Google Scholar 

  7. Fisher RI, DeVita VT, Jr, Hubbard SM, Longo DL, Westley R, Chabner BA, Young RC (1983) Diffuse aggressive lymphoma: Increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy. Ann Intern Med 98: 304–309

    Google Scholar 

  8. Forman SJ, Blume KG, Krance RA, Miner PJ, Metter GE, Hill LR, O'Donnell MR, Nademanee AP, Snyder DS (1987) A prospective randomized study on acute graft-versus-host disease in 107 patients with leukemia: Methotrexate/prednisone versus cyclosporin A/ prednisone. Transpl Proc 19: 2605–2607

    Google Scholar 

  9. Karnofsky DA (1961) Meaningful clinical classification of therapeutic responses to anti-cancer drugs. Clin Pharmacol Ther 2: 709–712

    Google Scholar 

  10. Keable H, Rybka WB, Ti TY, Richards GK (1981) Low dose gastrointestinal sterilization regimen in bone marrow transplantation (BMT). Annals RCPSC 14: 200 (abstract)

    Google Scholar 

  11. Klimo P, Connors JM (1985) MACOP-B chemotherapy for the treatment of advanced diffuse large-cell lymphoma. Ann Intern Med 102: 596–602

    Google Scholar 

  12. Levine AM, Forman SJ, Meyer PR, Koehler SC, Liebman H, Paganini-Hill A, Pockros A, Lukes RJ, Feinstein DI (1983) Successful therapy of convoluted T-lymphoblastic lymphoma in the adult. Blood 61: 92–98

    Google Scholar 

  13. Linker CA, Levitt LJ, O'Donnell MR, Ries CA, Link MP, Forman SJ, Farbstein MJ (1987) Improved results of treatment of adult acute lymphoblastic leukemia. Blood 69: 1242–1248

    Google Scholar 

  14. Magrath IT, Janus C, Edwards BK, Spiegel R, Jaffe ES, Berard CW, Miliauskas J, Morris K, Barnwell R (1984) An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 63: 1102–1111

    Google Scholar 

  15. McKelvey EM, Gottlieb JA, Wilson HE, Haut A, Talley RW, Stephens R, Lane M, Gamble JF, Jones SE, Grozea PN, Gutterman J, Coltman CA, Jr, Moon TE (1976) Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38: 1484–1493

    Google Scholar 

  16. O'Leary M, Ramsay NKC, Nesbit ME, Jr, Hurd D, Woods WG, Krivit W, Kim TH, McGlave P, Kersey J (1983) Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults: A pilot study. Am J Med 74: 497–501

    Google Scholar 

  17. Petz LD, Yam P, Wallace RB, Stock D, Lange G, Knowlton RG, Brown VA, Donis-Keller H, Forman SJ, Blume KG (1987) Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood (submitted for publication)

  18. Phillips GL, Herzig RH, Lazarus HM, Fay JW, Griffith R, Herzig GP (1986) High dose chemotherapy, fractionated total body irradiation and allogeneic marrow transplantation for malignant lymphoma. J Clin Concol 4: 480–488

    Google Scholar 

  19. Picozzi VJ, Coleman CN, Cox RS, Cohen JR, Rosenberg SA, Rogoway WM (1984) Lymphoblastic lymphoma in adults: The Stanford-NCOG experience. Blood 64: Suppl. 1: 183 a (abstract)

    Google Scholar 

  20. Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H, Mellits D, Sensenbrenner LL, Stuart RK, Yeager AM (1983) Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309: 1347–1353

    Google Scholar 

  21. Shank B, Hopfan S, Kim JH, Chu FCH, Grossbard E, Kapoor N, Kirkpatrick D, Dinsmore R, Simpson L, Reid A, Chui C, Mohan R, Finegan D, O'Reilly RJ (1981) Hyperfractionated total body irradiation for bone marrow transplantation: I. Early results in leukemia patients. Int J Radiation Oncoloy Biol Phys 7: 1109–1115

    Google Scholar 

  22. Skarin AT, Canellos GP, Rosenthal DS, Case DC, MacIntyre JM, Pinkus GS, Moloney WC, Frie E III (1983) Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol 1: 91–98

    Google Scholar 

  23. Slater DE, Mertelsmann R, Koziner B, Higgins C, McKenzie S, Schauer P, Gee T, Straus D, Kempin S, Arlin Z, Clarkson BD (1986) Lymphoblastic lymphoma in adults. J Clin Oncol 4: 57–67

    Google Scholar 

  24. Sullivan KM, Appelbaum FR, Horning SJ, Rosenberg SA, Thomas ED (1986) Selection of patients with Hodgkin's disease and non-Hodgkin's lymphoma for bone marrow transplantation. Int J Cell Cloning 4: Suppl. 1: 94–106

    Google Scholar 

  25. Thomas ED (1983) Marrow transplantation for malignant diseases. J Clin Oncol 1: 517–531

    Google Scholar 

  26. Thomas ED, Storb R (1970) Technique for human marrow grafting. Blood 36: 507–515

    Google Scholar 

  27. Weinstein HJ, Cassady JR, Levey R (1983) Long term results of the APO protocol (vincristine, doxorubicin (adriamycin) and prednisone) for treatment of mediastinal lymphoblastic lymphoma. J Clin Oncol 1: 537–541

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Bone Marrow Transplantation, City of Hope National Medical Center, 1500 E. Duarte Road, 91010, Duarte, California, USA

    A. P. Nademanee, S. J. Forman, G. M. Schmidt, P. J. Bierman, D. S. Snyder, M. R. O'Donnell, J. A. Lipsett & K. G. Blume

Authors
  1. A. P. Nademanee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. J. Forman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. M. Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. J. Bierman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. S. Snyder
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. R. O'Donnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. A. Lipsett
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K. G. Blume
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nademanee, A.P., Forman, S.J., Schmidt, G.M. et al. Allogeneic bone marrow transplantation for high risk non-hodgkin's lymphoma during first complete remission. Blut 55, 11–18 (1987). https://doi.org/10.1007/BF00319636

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00319636

Key words

Search

Navigation